Results 221 to 230 of about 58,791 (313)

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation [PDF]

, 2020
openaire   +1 more source

A UK key opinion leader perspective: Navigating the immunological and logistical transformation brought by stem cell‐derived islets for the treatment of type 1 diabetes

Diabetic Medicine, EarlyView.
Abstract Aims To explore UK key‐opinion leader perspectives on the future role of stem cell‐derived islets (sc‐islets) in islet transplantation for people with type 1 diabetes (T1D). Methods Four UK‐based key‐opinion leaders evaluated current limitations of donor islet transplantation and reviewed emerging evidence, clinical pathways and logistical ...
Thomas Strakosch, Shareen Forbes
wiley   +1 more source

Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]

JACC Adv
Aghel N, Wang V, Leong D, Lui M, Fu L, Kang J, Khalaf D, Walker I, Hillis C, Leber B, Klimis H, Holbrook A, Demers C, Joseph P, Lepic K, Garcia-Horton A, Berg T, Lipton JH, Duong M, Turner J, Ma J.   +20 more
europepmc   +1 more source

Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan

British Journal of Haematology, EarlyView.
Takafumi Furumoto, Koji Ando, Eo Toriyama, Tomoko Hata, Hikaru Sakamoto, Masahiko Chiwata, Hideaki Kitanosono, Jun Nakashima, Takeharu Kato, Masataka Taguchi, Makiko Horai, Hidehiro Itonaga, Shinya Sato, Yasushi Sawayama, Daisuke Imanishi, Yoshitaka Imaizumi, Tatsuro Jo, Shinichiro Yoshida, Yukiyoshi Moriuchi, Yasushi Miyazaki   +19 more
wiley   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia. [PDF]

Ann Hematol
Chen J, Li J, Wang Z, Huang Z, Lin J, Ou J, Xu X, Tang B, Ding C, Cai Z, Lin R, Li X, Liu Q, Zhou H.   +13 more
europepmc   +1 more source

Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation? [PDF]

Baptiste Le Calvez, Maxime Jullien, Jean Hugues Dalle, C. Rénard, Charlotte Jubert, Arthur Sterin, Catherine Paillard, Anne Huynh, Sarah Guenounou, Bénédicte Bruno, Virginie Gandemer, Nimrod Buchbinder, Pauline Simon, Cécile Pochon, Anne Sîrvent, Dominique Plantaz, Justyna Kanold, Marie C. Béné, Fanny Rialland, Audrey Grain, Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)   +20 more
openalex   +1 more source

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

British Journal of Haematology, EarlyView.
Olayinka Okeleji, David McCall, Branko Cuglievan, Amber Gibson, Demetrios Petropoulos, Priti Tewari, Jeremy Connors, Irtiza N. Sheikh   +7 more
wiley   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

European Journal of Haematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot, Frederic Baleydier, Laure Pittet, Geraldine Blanchard‐Rohner   +3 more
wiley   +1 more source

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study. [PDF]

Blood Adv
Tsilifis C, Raedler J, Renke J, Medinger M, Laberko A, Haraldsson Á, Patel N, Ciznar P, Wong M, Keogh SJ, Gray P, Mitchell R, Bigley V, Elcombe S, Hauck F, Albert MH, Tholouli E, Herwadkar A, Elkhalifa S, Kosmidis C, Callisti G, Burroughs LM, Chen K, Carpenter B, Fox TA, Morris EC, Uppuluri R, Raj R, Yanagimachi M, Buddingh EP, Oikonomopoulou C, Gonzalez C, Dimitrova D, Kanakry JA, Arnold D, Pai SY, Slatter MA, Pearce MS, Worth A, Freeman AF, Gennery AR.   +40 more
europepmc   +1 more source